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Abstract 
Tubulin posttranslational modifications are currently emerging as important regulators of the 
microtubule cytoskeleton and thus have a strong potential to be implicated in a number of 
disorders. Here we review the latest advances in understanding the physiological roles of 
tubulin modifications, and their link to a variety of pathologies.  
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Tubulin posttranslational modifications as regulators of microtubule functions 
Microtubules are one of the major components of the eukaryotic cytoskeleton and carry out a 
wide variety of key functions in virtually every cell. Microtubules are essential for cell 
polarity, cell shape and intracellular transport. They build the mitotic and meiotic spindles, 
which are the key structures to divide chromosomes during cell division. Microtubules are 
also assembling specialized structures such as axonemes, which are the backbones of cilia and 
flagella, centrioles, the core structures of centrosomes, or marginal bands in blood platelets. 
Notwithstanding the multiple structures they build, microtubule filaments are always 
assembled from highly conserved dimers of α- and β-tubulin, which raises the question of 
how they are able to adapt to so many different functions.  
In living cells, microtubules can interact with specific sets of microtubule-associated proteins 
(MAPs), including molecular motors and proteins that regulate microtubule dynamics. Thus, 
specialized microtubule functions depend to a large extend on which subset of MAPs they 
interact with. An emerging mechanism that can directly, and most likely selectively control 
these interactions are tubulin posttranslational modifications. Posttranslational modifications 
of tubulin have been known for many decades, however their functions have mostly remained 
elusive. This has changed over the last decade, when many of the enzymes involved in the 
catalysis of these modifications have been identified.  
Mechanistic studies revealed that these modifications can selectively control the functions of 
microtubules by either directly controlling their mechanical properties, and thus, their 
stability, or by regulating the plethora of interactions with MAPs. These initial insights have 
underpinned the idea that tubulin modifications can form a kind of a ‘tubulin code’, which 
programs selected microtubules for specific intracellular functions (reviewed in Janke, 2014; 
Song and Brady, 2015)(cite snapshot here, Magiera et al.). Recently, the manipulation of 
tubulin-modifying enzymes in different model organisms has led to a significant advance in 
the understanding of the physiological contributions of these modifications and suggested 
links to pathologies. Moreover, the first direct links to human diseases have been identified 
with the discovery of mutations in genes encoding tubulin-modifying enzymes. Here we 
review the current state of understanding of tubulin posttranslational modifications in mouse 
models and human pathologies.  
 
The essential role of tubulin modifications for cilia and flagella makes them risk factors for 
many cilia-related disorders 
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Most of the known tubulin modifications strongly accumulate at axonemes, the microtubule-
based core structures of eukaryotic cilia and flagella. All functional data so far point to 
important roles of tubulin modifications in ciliary maintenance and function (Wloga et al., 
2017). In humans, disorders of cilia can lead to a wide range of pathologies, commonly 
referred to as ciliopathies (Reiter and Leroux, 2017). These can be related to dysfunctions of 
motile cilia and flagella, but also to defects of the non-motile, primary cilia.  
The beating of motile cilia and flagella is powered by axonemal dynein motors. Previous 
work identified tubulin polyglutamylation (addition of multiple glutamate residues to the C-
terminal tubulin tails; Magiera et al. 2018) as an important regulator of this beating, and thus 
essential for ciliary function. Mutations in glutamylases (TTLL1, TTLL9) and deglutamylases 
(CCP1, CCP5) were linked to aberrations in spermatogenesis and sperm motility in mice, 
which resulted in male infertility (Konno et al., 2016; Mullen et al., 1976; Vogel et al., 2010; 
Wu et al., 2017). Alterations in tubulin polyglutamylation also affects the beating of other 
types of motile cilia, such as ependymal cilia in the brain ventricle (Bosch Grau et al., 2013), 
or airway cilia (Ikegami et al., 2010; Konno et al., 2016). While inactivation of the 
polyglutamylase TTLL1 leads to respiratory disorders in mice (Ikegami et al., 2010), no 
human disease directly linking aberrations of polyglutamylation to defects in motile cilia or 
sperm flagella has been identified so far.  
Non-motile, or primary cilia, are found on many human cell types where they fulfill essential 
functions as sensory organelles and signaling hubs. In a mouse model with a mutation in the 
deglutamylase CCP1, upregulated polyglutamylation leads to degeneration of photoreceptors 
in the retina. Photoreceptors contain a modified form of primary cilia, the connecting cilium, 
which may become dysfunctional due to hyperglutamylation, and cause these cells to 
degenerate (Marchena et al., 2011). The importance of this mechanism for humans has been 
recently confirmed by the discovery of mutations in the tubulin deglutamylase CCP5 in 
human vision disorders (Astuti et al., 2016; Branham et al., 2016; Kastner et al., 2015).  
Glycylation (addition of multiple glycine residues to the C-terminal tubulin tails, Magiera et 
al. 2018) is, in contrast to all other known tubulin modifications, predominantly found in cilia 
and flagella (Gadadhar et al., 2017; Wloga et al., 2017). Because of its specificity for cilia, 
glycylation is predestined to be a specific risk factor for ciliopathies. Tubulin glycylation is 
essential for the integrity of motile cilia in mouse ependymal cells (Bosch Grau et al., 2013), 
and for the control of primary cilia length (Gadadhar et al., 2017). Absence of glycylation in 
photoreceptors leads to shortening of the connecting cilium of these cells, which is followed 
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by retinal degeneration in mice (Bosch Grau et al., 2017). A rather unexpected link between 
glycylation and cancer was found in colorectal cancer. Knockout of the glycylase TTLL3 in 
mouse led to loss of primary cilia in colon and accelerated the proliferation of cancerous 
lesions. Strikingly, downregulation of TTLL3 expression was linked to colon cancer in human 
patients, thus confirming the relevance of this mechanism for the human disease (Rocha et al., 
2014). 
Other tubulin modifications, such as detyrosination (removal of the ultimate gene-encoded 
tyrosine residue from a-tubulin), ∆2-tubulin (removal of the penultimate glutamate from 
detyrosinated a-tubulin; (Johnson, 1998) and acetylation of the luminal lysine-40 residue of 
a-tubulin (Wloga et al., 2017; Magiera et al. 2018) are strongly enriched on axonemal 
microtubules of cilia and flagella. Among these, acetylation has been shown to have an effect 
on sperm morphology and motility as mice without the tubulin acetyl transferase αTAT1 are 
subfertile (Kalebic et al., 2013). Considering that human sperm is more prone to qualitative 
and quantitative deficiencies than their mouse counterparts, mutations that lead to subfertility 
in mice could potentially cause male sterility in human (Kherraf et al., 2017).  
 
Perturbed tubulin modifications lead to neurodevelopmental and neurodegenerative 
disorders  
Cytosolic microtubules are also subject to post-translational modification.  Neurons present 
an interesting case as they are the only known cell type in which tubulin posttranslational 
modifications are strongly enriched on most cytosolic microtubules. The neuronal 
microtubule cytoskeleton is involved in neuronal differentiation and connectivity, and plays a 
key role in intracellular transport over long distances. Polyglutamylation accumulates during 
neuronal differentiation and is therefore considered a potential key regulator of these different 
functions of neuronal microtubules.  
An important insight into the physiological role of polyglutamylation for neurons came with 
the discovery that a well-characterized mouse model for neurodegeneration, the Purkinje-cell 
degeneration (pcd) mouse (Mullen et al., 1976), bears a mutation in the gene encoding a 
deglutamylase enzyme, CCP1. The mutation leads to excessive accumulation of tubulin 
polyglutamylation specifically in regions of the nervous system that undergo degeneration 
(Rogowski et al., 2010). The most emblematic neurons that degenerate in the pcd mouse are 
Purkinje cells in the cerebellum and Mitral cells in the olfactory bulb (Mullen et al., 1976). 
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The timing of the degeneration of these two neuronal populations is different, which could be 
related to their individual susceptibilities to the deleterious insults.  
The correlation between excessive polyglutamylation and neurodegeneration observed in pcd 
mice raises the possibility that many other neuron types could degenerate upon 
pathologically-upregulated tubulin polyglutamylation. This could be either induced by 
mutations in one of the modifying enzymes, or by defects in regulatory circuits that control 
the levels of this modification. So far, little is known about the molecular mechanisms that are 
controlled by polyglutamylation in neurons. Initial observations suggested an important role 
in the regulation of axonal transport with an impact on synaptic transmission (Ikegami et al., 
2007; Maas et al., 2009), and it is also likely that it affects microtubule dynamics via the 
regulation of the microtubule-severing enzyme spastin (Lacroix et al., 2010; Valenstein and 
Roll-Mecak, 2016). 
Detyrosination and ∆2-tubulin are prominent modifications in neurons and found on all 
microtubules except those of the growth cone. Functional insight into the importance of these 
modifications came from tubulin-tyrosine ligase (TTL) knockout mice, which show strongly 
upregulated levels of detyrosinated and ∆2-tubulin in the brain. TTL-knockout mice die 
perinatally due to massive defects in brain architecture, in particular in the cortico-thalamic 
loop (Erck et al., 2005). The most likely reasons for these defects are aberrant timing and 
extent of neurite outgrowth (Erck et al., 2005; Prota et al., 2013). Milder alterations of this 
modification could be involved in neurodevelopmental disorders in human, however no such 
cases have been found so far. The recent discovery of the enzymes catalyzing detyrosination 
(Aillaud et al., 2017; Nieuwenhuis et al., 2017) now allows a more thorough analysis of the 
enzymatic machinery that controls the detyrosination / tyrosination cycle and might thus point 
to disease links in humans.  
Acetylation is enriched on all neuronal microtubules. During neuronal development, the 
modification controls axon branching (Wei et al., 2017) and plays a role in migration and 
morphological development of cortical neurons (Li et al., 2012). These functions could be 
explained by the recent finding that tubulin acetylation renders microtubules resistant to 
mechanical stress (Xu et al., 2017). However, given that acetylation is located in the 
inaccessible lumen of microtubules, the finding that this modification can also control axonal 
transport came as a surprise. Axonal transport defects have been linked to decreased tubulin 
acetylation in a range of neurodegenerative disorders, such as Huntington’s disease 
(Dompierre et al., 2007), Charcot-Marie-Tooth disease (d'Ydewalle et al., 2011; Kim et al., 
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2016), Amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (Godena et al., 2014). In 
these studies, which used mouse models or neurons obtained from patient-derived pluripotent 
stem cells, chemical inhibition of the deacetylating enzyme HDAC6 was sufficient to restore 
normal tubulin acetylation levels as well as normal axonal transport. To what extent 
acetylation alone is responsible for the observed transport defects remains to be verified, 
particularly because a mouse lacking tubulin acetyl transferase (ATAT1) merely showed 
defects in touch sensation but did not develop any of the expected degenerative phenotypes 
despite the complete absence of tubulin acetylation (Morley et al., 2016).  
 
Modifications of platelet microtubules and their implications in bleeding disorders 
Blood platelets are essential for the arrest of bleeding following injury, and their distinctive 
shape is maintained by a circular assembly of microtubules, the marginal band. Microtubules 
in the marginal band are rapidly reorganized during the process of platelet activation, which 
leads to blood clotting. The precise control of this peculiar microtubule assembly is thus an 
important factor in the function of platelets. Detyrosination, ∆2-tubulin and acetylation have 
been detected on microtubules of marginal band (Diagouraga et al., 2014). Defects in tubulin 
acetylation affect the maturation of megakaryocytes (the precursors of platelets), and thus 
platelet formation (Iancu-Rubin et al., 2012). A tight control of acetylation and deacetylation 
events is further important during platelet spreading after activation (Sadoul et al., 2012). It is 
thus possible that defects in tubulin acetylation may play a role in human bleeding disorders.  
 
Tubulin detyrosination in muscle functions and implications in cardiac diseases 
Tubulin detyrosination accumulates at early steps of muscle cell differentiation, while 
acetylation levels rise later in this process. It has recently been demonstrated that tubulin 
detyrosination affects mechanotransduction in muscle cells (Kerr et al., 2015), and is 
important for load-bearing of buckling microtubules during cardiomyocyte contraction. 
Excess or diminished tubulin detyrosination changes the stiffness of the cardiomyocytes, thus 
leading to cardiac dysfunction. Upregulated tubulin detyrosination was found in patients 
diagnosed with hypertrophic and dilated cardiomyopathies (Robison et al., 2016). These first 
clinical links indicate that alterations of the tyrosination / detyrosination balance could be a 
risk factor for heart failure and be more generally linked to muscle dysfunctions in a range of 
different diseases.  
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Posttranslational modifications of tubulin in cell division control: possible implications for 
cancer 
Most of the known tubulin modifications have been detected on microtubules of the cell 
division machinery, such as mitotic and meiotic spindles, midbody microtubules, and 
particularly, on centrioles, the microtubule-based core structures of the centrosomes. Tubulin 
modifications might control the precision of cell division; for instance, detyrosination, which 
impacts binding of a kinetochore-associated motor protein CENP-E, helps guide all 
chromosomes towards the metaphase plate in mitosis, and absence of this tubulin 
modification leads to misaligned chromosomes (Barisic et al., 2015). This deficit could lead 
to aneuploidy, a hallmark of cancer.  
There are several indications that deregulated detyrosination is indeed linked to cancer. 
Differential expression of TTL correlates with poor prognosis in neuroblastoma tumors (Kato 
et al., 2004), and detyrosination of tubulin was particularly prominent in aggressive subtypes 
of breast cancer (Mialhe et al., 2001). Moreover, the recent discovery that vasohibins are the 
enzymes catalyzing detyrosination (Aillaud et al., 2017; Nieuwenhuis et al., 2017) provides 
new links between this tubulin modification and already known associations between 
vasohibin dysfunctions and cancer (Du et al., 2017).  
In female meiosis, detyrosinated microtubules are asymmetrically enriched on one half of the 
meiotic spindle, which drives non-Mendelian chromosome transmission in mouse oocytes 
(Akera et al., 2017). This shows that tubulin modifications can impact inheritance, and thus 
might affect the transmission of familial monogenic disorders, however no implication in a 
human pathology has so far been described.  
Acetylation and polyglutamylation are both enriched on mitotic and meiotic spindle 
microtubules, midbody microtubules, and centrioles, however their functional contribution is 
yet to be elucidated. Injection of anti-glutamylation antibodies into dividing cells 
compromises centrosome integrity (Bobinnec et al., 1998), which suggests that the 
polyglutamylation of the centrioles is important for centrosome functions. Though no human 
disorder has been linked to tubulin modifications of centrioles, aberrations in these 
modifications might induce centrosome abnormalities, which are common hallmarks of 
cancer.  
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Conclusions and perspectives 
Recent functional studies, most of them in mouse models, hint at a wide range of potential 
implications of tubulin posttranslational modifications in pathologies. Several predictions of 
disease-causing roles for tubulin modifications are now confirmed in human disorders, often 
with phenotypes highly similar to the ones observed in the mouse models. It is likely that the 
rapid advances in human genome profiling will uncover novel links between human 
pathologies and aberrant tubulin posttranslational modifications in the near future. Once these 
links are identified, it will be essential to determine how altered tubulin modifications 
contribute to the respective disease phenotypes. It will thus be necessary to further develop 
experimental systems that allow to directly measure the impact of tubulin modifications on 
microtubule properties and functions in vitro and in cell models. This could be challenging, as 
most of the known tubulin modifications appear to have rather subtle biological effects. While 
this might be one of the central reasons tubulin modifications have often been overlooked as 
regulators of biological processes, it also makes these modifications perfect candidates for 
risk factors of late-onset, or slow-developing disorders: In spite of being dispensable for basic 
functions of cells and organisms, fine-regulators might be important for their fitness and 
adaptability, and thus their resistance to potential disease-causing insults. It thus appears that 
a better understanding of the posttranslational regulation of the microtubule cytoskeleton 
might substantially change the way we perceive the implications of the cytoskeleton in human 
disease. As modifying enzymes are accessible targets for drug development (Huq and Wei, 
2010), small-molecule inhibitors of tubulin-modifying enzymes are promising candidates for 
drugs for an emerging panoply of pathologies related to aberrant tubulin modifications.  
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Figure 1: Known links between tubulin posttranslational modifications and disease 
pathologies  
The known disorders that originate from aberrations of tubulin posttranslational modifications 
are listed, and their discovery in either mouse models or human patients is indicated.  
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